Projects per year
Personal profile
External positions
Assistant Professor of Clinical Medicine, Weill Cornell Medical College
Sep 1 2021 → …
Research Area Keywords
- Cancer
Fingerprint
Dive into the research topics where Shilpan Shah is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A Study Comparing Talquetamab in Combination With Daratumumab or in Combination With Daratumumab and Pomalidomide Versus Daratumumab in Combination With Pomalidomide and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma
Ganguly, S., Petkova, J., Pingali, S. R. & Shah, S.
3/30/23 → …
Project: Clinical Trial
-
A Phase 3 Open-Label, Randomized Study of Fixed Duration Pirtobrutinib (LOXO-305) Plus Venetoclax and Rituximab Versus Venetoclax and Rituximab in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BRUIN CLL-322)
Shah, S., Ganguly, S., Petkova, J., Pingali, S. R. & Rice, L.
9/21/22 → …
Project: Clinical Trial
-
A Phase 1 Study of SEA-CD70 in Myeloid Malignancies
Shah, S., Ganguly, S. & Pingali, S. R.
Project: Clinical Trial
-
Long term outcomes in older patients with primary central nervous system lymphoma: an analysis of the Texas Cancer Registry
Burns, E. A., Sanchez, C. G., Mathur, S., Guerrero, C., Muhsen, I. N., Sarfraz, H., Hu, C. C. A., Tang, C. H. A., Shah, S. S., Tremont, I. W., Teh, B., Ganguly, S. & Pingali, S. R. K., May 2023, In: Annals of Hematology. 102, 5, p. 1111-1120 10 p.Research output: Contribution to journal › Article › peer-review
-
Cell-free DNA 5-hydroxymethylcytosine is an emerging marker of acute myeloid leukemia
Shao, J., Wang, S., West-Szymanski, D., Karpus, J., Shah, S., Ganguly, S., Smith, J., Zu, Y., He, C. & Li, Z., Dec 2022, In: Scientific Reports. 12, 1, 12410.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations -
Use of ifosfamide, carboplatin and etoposide in combination with brentuximab vedotin or romidepsin based on CD30 positivity in relapsed/refractory peripheral T-cell lymphoma
Gentille, C., Sarfraz, H., Joshi, J., Randhawa, J., Shah, S. & Pingali, S. R., Jul 2022, In: Cancer Reports. 5, 7, e1581.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Multiple myeloma with concurrent immune thrombocytopenic purpura
Sarfraz, H., Anand, K., Liu, S. & Shah, S., 2020, In: ecancermedicalscience. 14, 1012.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
The development of T-cell malignancies in patients with pre-existing myeloproliferative neoplasms: A report of three cases
Burns, E. A., Anand, K., Chung, B., Shah, S., Randhawa, J. K. & Pingali, S. R., 2020, In: ecancermedicalscience. 14, 1011.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations